Drugs Pharmaceuticals Protein Production 
Drug Discovery World
FEBRUARY 13, 2023
In the time that has passed since SLAS2022 in Boston, USA, the drug discovery industry has had to deal with all manner of external obstacles, from the war in Ukraine, to how Brexit has changed the world’s relationship with the UK, and the post-Covid-19 catch-up now that vaccines have rolled out internationally.
Drug Discovery World
NOVEMBER 27, 2023
Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. Prioritising critical attributes in the upstream workflow is crucial for predicting and preventing challenges downstream, ultimately avoiding high development costs and delays in drug approvals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
JULY 24, 2023
Even with standardised methods, it typically takes months to achieve the first useful production of a biological drug. Cell-Free Protein Synthesis (CFPS) CFPS, by contrast, brings the key advantages of greater speed and flexibility than cell- and fermentation-based production.
Drug Target Review
MARCH 15, 2024
The discovery and development phases of biotherapeutic drugs leverage multiple technologies and processes across upstream and downstream stages of the bioprocess workflow. Selecting the appropriate upstream tools is key to avoiding challenges downstream, ultimately reducing development costs and delays in drug approvals.
Drug Target Review
NOVEMBER 1, 2023
Could you provide an overview of your research on target directed cancer drug discovery, particularly your focus on protein lagging interactions. I work in the Centre for Cancer Drug Discovery (CCDD) at The Institute of Cancer Research in London, which is an academic drug discovery centre. 2013) 56, 2059-2073.
Drug Discovery World
NOVEMBER 17, 2022
Lu Rahman selects some recent synthetic biology innovations and the potential they hold to benefit drug discovery. . The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape.
The Pharma Data
JANUARY 16, 2021
Etta Biotech”), to set up a high titer transient protein expression platform for high quality protein production using JS Bio’s transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech’s transient transfection high titer protein expression platform. About JS Bio.
Expert insights. Personalized for you.
130 
Let's personalize your content